SCHEMBL3142295

SCHEMBL3142295

Cc1cc(-c2ccccc2)nc2cc(-c3nn(C4CC(CN5CCC5)C4)c4ncnc(-c5ccccn5)c34)ccc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 15/20 0.42
EGFR P00533 6/20 0.42
KDR P35968 5/20 0.42
INSR P06213 5/20 0.42
CYP3A4 P08684 1/20 0.42
PIK3CG P48736 4/20 0.36
PIK3CD O00329 4/20 0.36
PIK3CA P42336 3/20 0.36
PIK3CB P42338 3/20 0.36
PRKDC P78527 2/20 0.36
SRC P12931 2/20 0.36
ABL1 P00519 2/20 0.36
EPHB4 P54760 2/20 0.36
HCK P08631 1/20 0.36
MTOR P42345 1/20 0.36
BTK Q06187 4/20 0.36
LCK P06239 3/20 0.36
RET P07949 3/20 0.36
KIT P10721 3/20 0.36
LYN P07948 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL399523 0.89 PIK3CD (0.47) IGF1REGFRKDRINSRCYP3A4
SCHEMBL397798 0.88 EGFR (0.47) IGF1REGFRKDRINSRCYP3A4
SCHEMBL5138247 0.85 IGF1R (0.42) IGF1REGFRKDRINSRCYP3A4
SCHEMBL398652 0.79 PIK3CD (0.43) IGF1REGFRKDRINSRPIK3CG
SCHEMBL400175 0.78 PIK3CD (0.51) IGF1REGFRKDRINSRCYP3A4
SCHEMBL400678 0.77 BTK (0.50) IGF1REGFRKDRINSRPIK3CG
SCHEMBL5143848 0.77 IGF1R (0.52) IGF1REGFRKDRINSRCYP3A4
SCHEMBL396767 0.77 EGFR (0.58) IGF1REGFRKDRINSRCYP3A4
SCHEMBL400677 0.76 PIK3CD (0.47) IGF1REGFRKDRCYP3A4PIK3CG
SCHEMBL5179813 0.76 PIK3CD (0.46) IGF1REGFRKDRPIK3CGPIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2168968-B1 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors OSI PHARMACEUTICALS LLC (US) 2017-08-23 EP disclosed
EP-2168968-A1 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors OSI Pharmaceuticals, Inc. (US) 2010-03-31 EP disclosed